Thursday, 6 June 2013

Zydus New Chemical Entity Lipaglyn, has been approved by Drug Controller General of India.




Lipaglyn is the first Glitazar to be approved in the world and is the first NCE discovered and developed indigenously by an "Indian Pharma Company"

Posted by at

2 comments:

  1. Unknown6 June 2013 at 18:21

    Great to see an Indian company has launched NCE
    Kudos to Zydus and its R&D team

    ReplyDelete
  2. Prashanth Kumar Killi6 June 2013 at 18:36

    At last we got a breakthrough form the great INDIA, hope we may expect competitive spirit among other companies and see such NCE's in coming years..... "INCREDIBLE INDIA"

    ReplyDelete

Subscribe to: Post Comments (Atom)